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Abstract: Today, obesity is one of the leading causes of death. It also causes other diseases such as diabetes, cardiovascular
disease, and various types of cancer. Obesity is a multifactorial disease caused by factors such as genetics and
lifestyle. However, scientists imagine that about 40-70% of the disease originates from genetics. In this review,
we examined the role of different genes in obesity by examining 30 articles published on the role of genetics in
the obesity of Iranian men, according to their BMI, comorbidities and family history. We concluded that most
of the research has been done on the FTO, Hind III and S447 genes. We also showed an apparent relationship
between these genes and obesity. Finally, according to studies, FTO can be considered as the most important
and strongest contributor to obesity.
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1. Introduction
Obesity has become a major global problem and is recog-
nized as the fifth leading cause of death worldwide (1). Re-
cent estimates by the World Health Organization (WHO)
show that in 2016, more than 1.9 billion and 650 million
adults were overweight and obese, respectively. The propor-
tion of overweight by gender also shows that 39% of men and
40% of women are overweight worldwide (2). Many devel-
oping countries, such as Iran, are currently struggling with
obesity and problems associated with excess weight (3).
Obesity is a multifactorial disease caused by a constellation
of various elements such as genetics, environmental, so-
cial, and lifestyle-related factors (4). Raised BMI is a major
risk factor for non-communicable diseases such as cardio-
vascular diseases (mainly heart disease and stroke), diabetes
mellitus, musculoskeletal disorders (especially osteoarthri-
tis), and some cancers, including endometrial, breast, ovar-
ian, prostate, liver, gallbladder, kidney, and colon (2).
It is estimated that the cause of obesity in about 40 - 70% of
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the cases is presumed to be genetics (5). According to the
Genome-Wide Association Studies (GWAS), about 97 gene
loci and 835 genes in relation to obesity have been found (5,
6). Several genes implicated in monogenic obesity are in or
near loci, and subsequently associated with obesity-related
traits, including MC4R, BDNF, PCSK1, POMC, SH2B1, LEPR,
and NTRK2 (7). The most important of these genes are FTO
(5/ 8/11/ 13/ 22/ 23/ 24/ 25/ 26/ 27) Hind III, S447 (18/19/28)
PPARÎş2 (16/29), and UCP2 (30/ 31). The FTO gene is known
to be the most important gene causing obesity by increasing
the appetite (8).
Investigators pursue the susceptibility genes to improve our
understanding of the etiology of obesity. The primarily goal
is to utilize this knowledge for the improvement of human
health conditions through the development of new thera-
peutic or preventive treatments. Although this goal requires
operational information (which is widely unavailable today),
genetic variants for obesity-related traits have been exploited
to provide numerous insights into the biology of obesity and
its complications, as reviewed below. The purpose of this
review article is to examine the role of genetics in obesity
in Iranian men based on body mass index (BMI) and fam-
ily history. To prepare this review, international and national
databases (including Medline, Scopus, Clarivate Analytics,
Magiran, SID) were searched with keywords including: Obe-
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sity, Body Mass Index, Familial obesity, morbid obesity, Iran,
Gene, Genetics. In total, 78 articles were extracted, which fi-
nally 26 were used for the present review. Examining these
articles, we found no review article and no systematic review
in this regard. (Figure-1)
Figure 1: Flowchart of the studies included in the review.
1.1. Obesity based on BMI
Body Mass Index (BMI), calculated as the division of weight
(Kg) by squared height (in meters), is a global index used
to diagnosis obesity and overweight (9). According to the
definition, overweight is defined as a BMI between 25 and
29.9; while, obesity I defined as a BMI equal or greater than
30.
Research on the role of genes in human BMI is rising in
popularity in Iran (10). A kernel machine SNP analysis on the
cohort participant of Tehran Lipid and Glucose study (TLGS)
has shown that 97 genetic variants are involved in 2.7% of
overweight individuals (defined as (25<BMI< 29.9)) (11).
A study on the C825T polymorphism in the GNB3 gene
identified an association between TT genotype in the C825T
polymorphism and obesity. The authors estimated that the
probability of obesity in people with TT genotype in the
C825T polymorphism is nearly 75% (10). Another study on
adolescents showed a significant relationship between the
T allele in UCP3 C-55T polymorphism and obesity. The
prevalence of T allele of this polymorphism was estimated
as 72% in obese individuals in contrast to 40% in normal
individuals (12).
It has been shown that the FTO gene has had the strongest
association with obesity. Several polymorphisms of this
gene such as; rs1558902, rs3751812, rs9939609, rs9930506,
rs1421085, rs17817449, rs9930501 & rs9932754 have been
found to be related to obesity in human population (13).
On the other hand, investigation has shown that intake
of protein, carbohydrates, and fiber might reduce the risk
of rs1558902 polymorphism (8, 14). A 3.5-year follow-up
study on 4292 participants of Tehran Lipid and Glucose
Study showed that in carriers of the risk alleles rs1121980,
rs1421085, rs8050136, rs1781799 and rs3751812, BMI was
approximately 2-fold higher in individuals in the higher
quartile of western dietary pattern (full of processed red
meat and full-fat diary) compared with the first quartile. The
authors concluded that adults with higher genetic predispo-
sition to obesity are more susceptible to the harmful effects
of western dietary pattern (8). The association of healthy
diet with obesity-associated variants (FTO) also has been
shown in a nested case-control study, indicating that indi-
viduals with minor allele carriers of rs9939973, rs8050136,
rs1781749, and rs3751812 had lower risk of obesity when
they had higher scores on Mediterranean diet, compared
to wild-type homozygote genotype carriers. However, the
authors found no significant interaction between the genetic
risk score and Mediterranean diet on abdominal obesity.
The authors concluded that compared to those with lower
adherence to the Mediterranean diet and lower genetic risk
scores, higher adherence to the Mediterranean diet was
associated with lower obesity risk in subjects with more
genetic predisposition to obesity (15).
Mediterranean diet has also been studies on the context of
the rs3751812 polymorphism, which carries the T allele in
the TG + TT genotype (5). People with the AT or AA allele
in the rs9939609 polymorphism are more likely to be obese,
especially with a diet containing sweeteners and fried foods
(8). Because this polymorphism is associated with a lower
level of lipolysis in adipose tissue (23), people carrying
this type of polymorphism have a higher weight loss than
non-carriers if they use a healthy diet (8). The rs9930506
polymorphism with the GG genotype also has the strongest
association with BMIs greater than 30. In a school-based
study on male adolescents with body mass index (BMI)
higher than +âĂL’1 Z-score, it is shown that compared to
male adolescents without extra weight, higher BMI and
body fat percent and lower skeletal muscle percent were
more likely to have a newly found haplotype of rs9930506,
rs9930501 & rs9932754 (GGT) in the first intron of the FTO
with complete linkage disequilibrium (LD). The association
was remained after controlling for age, calorie intake and
physical activity (13). Another study showed that compared
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VEGF rs6993770 AT + TT
HSP70 126HSP70-2 AA
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IRS1 RR + GR
(reduce risk of obe-
sity)
to normal adolescent males, male adolscents with very high
BMI and lower skeletal muscle volume had the rs9930506,
rs9930501 and rs9932754 haplotypes in their first FTO gene
intron (23).
1.2. Sperm Factors
Metabolic Syndrome (MetS) as the most common form of
lipid abnormalities can increase Triglyceride (TG) level and
decrease High-Density Lipoprotein cholesterol (HDL) level.
The lipoprotein lipases (LPL), located at the 8p22 locus, plays
an important role in controlling MetS (16). A study on
blood samples of 750 students aged 10-18 years showed that
there were significant interactive effects from LPL polymor-
phisms and birth weight on HDL-C concentration, and also
effects from LPL polymorphisms and BMI on TG and HDL-
C concentrations. More specifically, the AG/GG genotype in
D9N polymorphism was associated with higher LDL-C (low-
density lipoprotein cholesterol) and lower HDL-C concen-
tration. Significant interactions were found for D9N poly-
morphism and birth weight in association with plasma HDL-
C concentration, and also for D9N polymorphism and BMI
in association with plasma triglyceride (TG) and HDL-C lev-
els. Significant interactions were found for S447X polymor-
phism and BMI in association with plasma TG and HDL-
C concentrations (16). Another investigation on the asso-
ciation of a polymorphism of the lipoprotein lipase (LPL)
rs328 and cholesteryl-ester-transfer-protein (CETP) rs5882
genes in relation to lipid profile concluded that there was
a significant association of LPL and CETP polymorphisms
with serum triglycerides and HDL-cholesterol. The re-
sults showed that in comparison to normal-weight subjects,
obese subjects had a significantly higher level of triglyc-
eride (TG), blood pressure, waist-circumference and fasting-
blood-glucose, and lower level of HDL-C. The LPL rs328-GG-
GC genotype was significantly related to a higher concentra-
tion of TG, compared to the CC wild-type; however, LPL and
CETP polymorphisms were not associated with obesity. Ad-
ditionally, the authors reported that obese-subjects carrying
the G allele of CETP had a significantly lower level of HDL-C
compared to those with C allele (17).
The most common LPL gene polymorphism is Hind III which
occurs when the thymine is converted to guanine at position
+ 495 in intron 8 and correlates with birth weight in terms of
HDL-C and BMI for TG and HDL-C. In a study on 233 obese
adolescents with BMI> 30 and 156 healthy adolescents with
BMI less than 25 as the control group, using the PCR- RFLP
examined the Hind III and S447X polymorphisms of the LPL
gene. The results of this experiment confirmed the relation-
ship between sex and LPL gene polymorphisms and the risk
of metabolic syndromes in the population of northern Iran
(16).
Another example of factors contributing to obesity is the MSY
region on the Y chromosome. This region consists of 3 seg-
ments AZFa, AZFb and AZFc, each of which contains differ-
ent genes. Researchers have found that microdeletions in
this area decrease androgen levels and increase BMI. In a
study on 180 subjects (44 obese, 94 overweight, and 42 nor-
mal) in Golestan Province of Iran, the authors found that
obese individuals with AZFc microdeletions, including gr/gr,
had reduced testosterone levels and increases obesity, espe-
cially in men (4). The balance between energy intake and
consumption is another factor contributed to the obesity.
Melanocortin-4-receptor (MC4R) is one of the most impor-
tant genes in energy homeostasis (18). There is a variant in
the 188 kb downstream region of this gene, called rs17782313,
which plays a role in increasing BMI. Research on Iranian
population shows that people with the CC genotype had a
higher fat level than those with the TT genotype and are
more likely to have a BMI greater than 25 (19). Another gene
involved in balancing energy intake is the ADRB3 gene at
the 8p12-p11.2 gene locus. This gene is mainly expressed
in adipose tissue and it plays a key role in regulating lipid
metabolism and thermogenesis. This gene has a B3 receptor
which, if translocation of Trp to Arg at position 64 of this re-
ceptor, decreases lipid metabolism by this gene and increases
BMI (20). Another gene that plays a role in the volume of adi-
pose tissue is the RBP4 gene, which is located in the 10q23-
q24 gene locus and is released from the liver and adipose tis-
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sue. This gene has two variants rs3758539 and rs10882273.
An investigation on 321 people in Isfahan city found a signif-
icant association between the G and A allele in the rs3758539
variant, which was significantly higher in individuals with
higher BMI and obesity. The authors also reported that peo-
ple with higher BMI had GA + AA genotypes more frequently
(21).
Obesity can be considered as both outcome and etiologic
cause for other disorders/diseases. Obesity is heavily asso-
ciated with cardiovascular diseases while Apo E gene, which
plays a role in cardiovascular disease (42), also has a close re-
lationship with its polymorphism and obesity. Although the
association between this gene and obese individuals is con-
troversial (22, 23). Unlike the two Apo E and NR1H3 genes,
the CD36 gene in the 7q11.2-7q21.11 gene locus has been
proposed as a candidate for BMI and MetS (24). The protein
from this gene has two polymorphisms rs10499859A> G and
rs13246513C> T.
According to other studies, another gene involved in MetS
is the VEGF gene with rs6921438, rs4416670, rs6993770, and
rs10738760 polymorphisms (25). The association between
AT and TT genotype in rs6993770 polymorphism was re-
ported as 49% and 15% in a study, respectively. The study
concluded that the AT and TT genotypes were associated
with increased levels of FBS and TG, causing MetS and obe-
sity (26).
Further study by Mardan-Nik et al. has identified the HSP70
gene as a candidate for obesity. The HSP70-2 gene encodes
a protein likely to be involved in obesity and also in coro-
nary heart diseases (27). Application of PCR-RFLP method on
317 Iranian individuals to confirm this hypothesis revealed
that there was a significant relationship between obesity and
polymorphism of 126HSP70-2.
1.3. Discussion
Many scientists now believe that there is a link between obe-
sity and lipid levels (17), increased triglyceride (TG) (18) and
LDL (19), decreased HDL-C (18), and also disrupted hor-
mones (6) such as Diponectin (20).
Reports suggest that adherence to a healthy diet will reduce
and modify the effect of the FTO on obesity (5). This is prob-
ably due to the role of fiber diet which produces fatty acids
such as acetate, propionate, and butyrate. These compounds
acetylate the histone tail of the FTO gene and do not allow
transcription of this gene (35). This creates a theory that bu-
tyrate inhibits histone deacetylase and aids in the expression
of genes such as PPAR, which, as PPAR- Ît’ activator, decrease
FTO gene expression and thereby reduce obesity (36). The
other two polymorphisms of the FTO gene, rs1421085 and
rs17817449, have less association with diet (26). In this re-
view article, we tried to examine the role of different genes in
obesity by examining about 30 articles published on the role
of genetics in the obesity of Iranian men, according to their
BMI, MetS and family history. In conclusion, most of this re-
search has been done on the FTO, HindIII and S447 genes,
all of which have shown the highest relationship between
these genes and obesity. Finally, according to studies, FTO
can be considered as the most important and strongest cause
of obesity. Despite the earlier intention to include the asso-
ciation of genetic traits with obesity in men population, we
realized later that there is not much to go in this field in Iran.
In other words, our review team was unable to find studies
on male population to adequately address the question in
hand. To overcome this problem, we attempted to include
genetic studies with subgroup comparisons based on gen-
der; however, much of the literature did not address gender-
specific genetic mechanisms for obesity. Another limitation
of our review is that this study was investigated genes that
are responsible for obesity; nevertheless, other interactions
that can indirectly decrease or increase gene expression and
subsequently lead to obesity are not included. Some of the
interactions that are overlooked in our review include gene
sensitivity, molecular mechanism, and gene methylation.
2. Conclusion
According to the literature, the effect of FTO gene alleles in
men and women were almost equal, and we found that men
with FTO gene polymorphisms were most associated with
obesity. A healthy diet such as diets full of protein and fiber
with removal of sweeteners and fried foods can control obe-
sity. In other words, even with the influence of genetics and
the susceptibility to obesity in these people, the environment
and living conditions of individuals can still have a signifi-
cant impact on their phenotype. However, diet has no effect
on the frequency of genes in this disease and can only be a
preventive or therapeutic agent.
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